Antidepressant Zoloft and generic version in short supply, FDA says

Drugmaker Lupin also cited a shortage of the active ingredient, as well as an increase in demand for the product, which is expected to be on backorder for several months.in the number of prescriptions filled per week between mid-February and mid-March for medicines to treat anxiety, depression and insomnia, according to Express Scripts, a prescription benefit plan provider.

The survey, which included responses from 1,468 adults, found 13.6 percent reported psychological distress in April 2020, up from 3.9 percent surveyed in 2018.The increase was most notable among Hispanics, adults under age 30 and people in low-income households. "Young adults in particular surprised me a bit," said Beth McGinty, lead author of the new report and associate professor in the department of health policy and management at the Johns Hopkins Bloomberg School of Public Health.

"We've been talking so much about how worried we are about older adults who may be isolated. But actually, it's young adults who seem to be having the most issues," she said. The survey did not ask participants why they had these feelings of despair, but McGinty said it likely reflects the pandemic's impact on education and job opportunities for younger adults just starting out in their careers.

Glad I stocked up!!

I get it.

I’m not sure because I’ve never taken them, but from what I’ve heard, don’t depressant drugs often make you feel more depressed lol?

I was going to take up drink8ng, but can’t remember to buy alcohol when I’m at the store because my glasses are fogged up.

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Antidepressant Zoloft and generic version in short supply, FDA saysThe shortage follows a sharp increase in reports of depression and anxiety in the U.S.
Source: YahooNews - 🏆 380. / 59 Read more »

Antidepressant Zoloft and generic version in short supply, FDA saysThe shortage follows a sharp increase in reports of depression and anxiety in the U.S.
Source: YahooNews - 🏆 380. / 59 Read more »

‘You could see the train wreck coming’: Inexperienced, dubious companies among many aiming to cash in on coronavirus antibody testsBuyer beware? Coronavirus antibody tests approved for sale by the FDA include companies with little or no background in medical testing. One sells vape pens, another male enhancement powders.
Source: USATODAY - 🏆 100. / 63 Read more »

FDA extends review of Novartis's OfatumumabNovartis AG said late Tuesday that the U.S. Food and Drug Administration has extended its review of the supplemental biologics license application for ofatumumab. The Swiss drug giant said regulatory action is expected in the U.S. in September 2020, anticipating approval for the targeted B-cell therapy for patients with relapsing multiple sclerosis in Europe by the second quarter of 2021.
Source: MarketWatch - 🏆 3. / 97 Read more »